argenx, VYVGART, VYVGART Hytrulo, Efgartigimod, Efgartigimod Alfa, Myasthenia Gravis, MG, Generalized Myasthenia Gravis, Ocular Myasthenia Gravis,

argenx Presents New VYVGART Data Across MG and CIDP AMSTERDAM, Netherlands — September 29, 2026 — argenx SE announced...